Cargando…
miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer
BACKGROUND: Ovarian cancer is the leading lethal gynecological cancer and is generally diagnosed during late-stage presentation. In addition, patients with ovarian cancer still face a low 5-year survival rate. Thus, innovative molecular targeting agents are required to overcome this disease. The pre...
Autores principales: | Cao, Shujun, Li, Na, Liao, Xihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851903/ https://www.ncbi.nlm.nih.gov/pubmed/33526047 http://dx.doi.org/10.1186/s13048-020-00760-2 |
Ejemplares similares
-
The suppressive role of miR-362-3p in epithelial ovarian cancer
por: Yuan, Jialing, et al.
Publicado: (2020) -
MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma
por: Wang, Dan, et al.
Publicado: (2018) -
miR-362-3p suppresses ovarian cancer by inhibiting LRP8
por: Li, Chun, et al.
Publicado: (2021) -
Evaluation of miR-362 Expression in Astrocytoma of Human Brain Tumors
por: Kheirollahi, Majid, et al.
Publicado: (2017) -
Silencing of Ago-2 Interacting Protein SERBP1 Relieves KCC2 Repression by miR-92 in Neurons
por: Barbato, Christian, et al.
Publicado: (2022)